Freedman LS - Search Results

1

Bayesian monitoring of phase II trials in cancer chemoprevention.

Cronin KA, Freedman LS, Lieberman R, Weiss HL, Beenken SW, Kelloff GJ. Cronin KA, et al. Among authors: freedman ls. J Clin Epidemiol. 1999 Aug;52(8):705-11. doi: 10.1016/s0895-4356(99)00063-3. J Clin Epidemiol. 1999. PMID: 10465313

2

Statistical analysis of animal cancer chemoprevention experiments.

Freedman LS, Midthune DN, Brown CC, Steele V, Kelloff GJ. Freedman LS, et al. Biometrics. 1993 Mar;49(1):259-68. Biometrics. 1993. PMID: 8513108

3

Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer.

Weiss HL, Urban DA, Grizzle WE, Cronin KA, Freedman LS, Kelloff GJ, Lieberman R. Weiss HL, et al. Among authors: freedman ls. Urology. 2001 Apr;57(4 Suppl 1):220-3. doi: 10.1016/s0090-4295(00)00979-1. Urology. 2001. PMID: 11295632 Clinical Trial.

4

Intraepithelial and postinvasive neoplasia as a stochastic continuum of clonal evolution, and its relationship to mechanisms of chemopreventive drug action.

Boone CW, Kelloff GJ, Freedman LS. Boone CW, et al. Among authors: freedman ls. J Cell Biochem Suppl. 1993;17G:14-25. doi: 10.1002/jcb.240531104. J Cell Biochem Suppl. 1993. PMID: 8007692 Review.

5

The what, why and how of Bayesian clinical trials monitoring.

Freedman LS, Spiegelhalter DJ, Parmar MK. Freedman LS, et al. Stat Med. 1994 Jul 15-30;13(13-14):1371-83; discussion 1385-9. doi: 10.1002/sim.4780131312. Stat Med. 1994. PMID: 7973217

6

Comparison of Bayesian with group sequential methods for monitoring clinical trials.

Freedman LS, Spiegelhalter DJ. Freedman LS, et al. Control Clin Trials. 1989 Dec;10(4):357-67. doi: 10.1016/0197-2456(89)90001-9. Control Clin Trials. 1989. PMID: 2691203

7

Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization.

Green SB, Corle DK, Gail MH, Mark SD, Pee D, Freedman LS, Graubard BI, Lynn WR. Green SB, et al. Among authors: freedman ls. Am J Epidemiol. 1995 Sep 15;142(6):587-93. doi: 10.1093/oxfordjournals.aje.a117679. Am J Epidemiol. 1995. PMID: 7653466

8

Approached to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative.

Freedman L, Anderson G, Kipnis V, Prentice R, Wang CY, Rossouw J, Wittes J, DeMets D. Freedman L, et al. Control Clin Trials. 1996 Dec;17(6):509-25. doi: 10.1016/s0197-2456(96)00016-5. Control Clin Trials. 1996. PMID: 8974210

9

The study of markers of biological effect in cancer prevention research trials.

Greenwald P, Witkin KM, Malone WF, Byar DP, Freedman LS, Stern HR. Greenwald P, et al. Among authors: freedman ls. Int J Cancer. 1992 Sep 9;52(2):189-96. doi: 10.1002/ijc.2910520206. Int J Cancer. 1992. PMID: 1521908 Review.

10

Bayesian design and analysis of two x two factorial clinical trials.

Simon R, Freedman LS. Simon R, et al. Among authors: freedman ls. Biometrics. 1997 Jun;53(2):456-64. Biometrics. 1997. PMID: 9192445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page